FDA D.I.S.C.O.: L-Glutamine for Sickle Cell Disease
Share:
Listens: 0
About
FDA medical oncologists discuss the July 7, 2017, approval of l-glutamine to reduce the acute complications of sickle cell disease. Released August 17, 2017
FDA Drug Information Updates
Science
FDA medical oncologists discuss the July 7, 2017, approval of l-glutamine to reduce the acute complications of sickle cell disease. Released August 17, 2017
